drugset / Trial / NCT07265466
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
RandomizedFactorialOpen-labelTreatment
Summary
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Timeline
- Start
- 2025-11-17
- Primary completion
- 2026-03-30
- Completion
- 2026-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apixaban | Small molecule | — | — |
| Subject | Aspirin | Small molecule | — | — |
| Subject | Atorvastatin | Small molecule | — | — |
| Subject | Clopidogrel | Small molecule | — | — |
| Subject | JP-1366 | Unknown | — | — |
Indications
No indication recorded.